Today, we announced that S&P Global Animal Health awarded our year-long flea & tick solution the Best New Companion Animal product. We remain committed to providing customers with innovative solutions that shape the future of animal health. Read more: https://t.co/S3lBQiT3oH
🏆 ¡CDV reconocida como Mejor Empresa de Salud Animal del Mundo 2024! 🌎
Un reconocimiento a nuestro compromiso con la sanidad animal. Seguimos innovando, creciendo y acompañando a productores y veteriinarios en cada desafío.
Gracias por ser parte!
S&P Global Animal Health Interview TriviumVet CEO Louise Grubb on upcoming product authorizations in 2024 and the TriviumVet pipeline. Thanks to @JHJournalist for catching up with us
"TriviumVet poised for debut approval in 2024"
https://t.co/NOfBrrv3CK
Check out the stellar lineup of companies who are attending #vethealthglobal2023 in only a few short weeks!
📅 June 26-28, 2023
📍Charlottetown, PE
➡️https://t.co/i4SzusngV7
Did you know...
A 60% global vaccination rate for beef cattle is associated with a 52.6% rise in
production
This rise is equivalent to the beef consumption of 3.1 billion people
Vaccination means more food secure communities
#WorldAnimalVaccinationDay
https://t.co/y2ycvMp7r4
Our CEO shared some interesting insights with @JHJournalist with the @SPGlobal recently when he discusses the commercialization of Veldona pet products and how we plan to expand it globally. Check out the full story below. #petHealth#animalhealth#interferon $AIMD $AIMDW
Almost here: Join our friends at @AHCorridor 12th annual Animalytix Market Update hosted online, 10 am CST on Feb 9. Learn more: https://t.co/jylzRVCqGD
Today marks the 10th anniversary of @Zoetis. It's been a decade since the largest animal health company was spun out from Pfizer into a standalone public entity. Since then, the firm’s market capitalization has risen from $16bn to nearly $80bn with shareholder return of 500%. ⬆️
These themes indicate why @Zoetis is a stand-out market leader and a business that has benefitted growth throughout the wider animal health industry. The sector has grown up a lot in the last 10 years, with Zoetis largely to thank for stimulating this ongoing evolution. 🔟🎂
Today marks the 10th anniversary of @Zoetis. It's been a decade since the largest animal health company was spun out from Pfizer into a standalone public entity. Since then, the firm’s market capitalization has risen from $16bn to nearly $80bn with shareholder return of 500%. ⬆️
@Zoetis has also diversified into new areas within its portfolio. It has finalized 19 acquisitions over the last decade, more than any other top 20 animal health companies. These deals have helped Zoetis move further into diagnostics, genetics and digital tech 💵💴💶💷